Matching epitopes in platelet refractoriness

摘要

In this issue of Blood, Marsh et al report that, in a prospective, randomized, noninferiority trial, HLA epitope-matched (HEM) platelet transfusions are not worse than HLA standard antigen-matched (HSM) platelet transfusions for HLA alloimmunized patients with platelet refractoriness.(1)